Results 31 to 40 of about 4,638,728 (306)

Community pharmacy wider roles project [PDF]

, 1999
In 1996 the NHS Executive’s Pharmaceutical and Optical Branch invited health authority bids to carry out pilots testing some form of extended role for community pharmacy. In 1997 it funded twelve pilots.
Woodward, J., Ruston, Annmarie, Edmunds, June, Stewart, Alan, Calnan, Michael .W., Colwill, S., Knight, J.   +6 more
core  

The relationship of pharmaceutical services toward the use of herbal medicine : Indonesian case

Jurnal Profesi Medika, 2020
Pharmaceutical services are services provided by a pharmacist in providing health information including the use of herbal medicines. The purpose of this study was to look at the relationship between pharmaceutical services and the use of herbal medicines
Putu Eka Arimbawa, Dewi Puspita Apsari, I Gusti Ngurah Agung Windra Wartana Putra, Muhammad Iqbal Fasa   +3 more
doaj   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Elderly People and Digital Pharmaceutical Services: Challenges, Needs and Solutions

Российский журнал гериатрической медицины
In the context of global population aging, ensuring the availability and quality of healthcare services for the elderly is becoming relevant. Digital healthcare, including pharmaceutical services, opens up new opportunities to improve their quality of ...
Yu. A. Lisenkova, I. A. Grigorieva
doaj   +1 more source

Making the investment case for national regulatory authorities

Journal of Pharmaceutical Policy and Practice, 2021
Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to attribute, thereby making NRAs undervalued ...
Gloria Twesigye, Tamara Hafner, Javier Guzman   +2 more
doaj   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, Khalaf O. Bushara, Chiadi U. Onyike, Sub H. Subramony, Jeremy D. Schmahmann, Brian J. Soher, Peter B. Barker, Thomas H. Mareci, Eva‐Maria Ratai, Lynn E. Eberly, Gülin Öz   +19 more
wiley   +1 more source

Artificial intelligence accelerates drug discovery and enhances commercialization efficiency

Discover Artificial Intelligence
Artificial Intelligence has enriched drug Discovery and development, making it faster and easier. This Review article summarizes the use of AI across various stages of drug discovery and development, as well as in marketing and commercialization. It also
Vrushab Sunil Pipada, Dileep J. Babu Bikkina, Suresh Kumar Joshi, Narendra Reddy Tharigoppala, Subhash Zade, Rajesh Vooturi   +5 more
doaj   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

The utility of Glaucoma Information Cards for grasping glaucoma subtypes: a single-center pilot study

Journal of Pharmaceutical Health Care and Sciences
Background In Japan, anticholinergic drugs were contraindicated for glaucoma, regardless of subtype. The contraindication in patients with open-angle glaucoma (OAG) led to excessive medication restrictions because anticholinergic drugs are associated ...
Yukinori Yamada, Tetsuya Murase, Emiko Mashida, Yuki Kakeda, Yuuka Shibata, Hiroaki Matsuo   +5 more
doaj   +1 more source

Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF312

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Intracerebral hemorrhage (ICH) causes high morbidity and mortality, with neurotoxic inflammation driven by infiltrating monocytes. This study is an in‐depth longitudinal examination of the immune response during the first week of ICH in the presence and absence of the immunomodulatory drug BAF312 (Siponimod).
Jonathan Howard DeLong, Sebastian Díaz‐Pérez, Kevin Navin Sheth, Jang‐Ho Cha, C. J. Malanga, Patricia G. M. Wagner, Nicole Pezous, Aurelie Hanin, Kyle B. Walsh, H. E. Hinson, Lauren Hachmann Sansing   +10 more
wiley   +1 more source